Author:
Rittling S R,Chambers A F
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ (2002) Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94: 513–521
2. Ariztia EV, Subbarao V, Solt DB, Rademaker AW, Iyer AP, Oltvai ZN (2003) Osteopontin contributes to hepatocyte growth factor-induced tumor growth and metastasis formation. Exp Cell Res 288: 257–267
3. Barraclough R, Chen HJ, Davies BR, Davies MP, Ke Y, Lloyd BH, Oates A, Rudland PS (1998) Use of DNA transfer in the induction of metastasis in experimental mammary systems. Biochem Soc Symp 63: 273–294
4. Bautista DS, Saad Z, Chambers AF, Tonkin KS, O'Malley F, Singhal H, Tokmakejian S, Bramwell V, Harris JF (1996) Quantification of osteopontin in human plasma with ELISA: basal levels in pre- and postmenopausal women. Clin Biochem 29: 231–239
5. Behrend EI, Craig AM, Wilson SM, Denhardt DT, Chambers AF (1994) Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res 54: 832–837
Cited by
359 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献